Evidence map›Paper›PMID 42565092›Full record

ArticleJournal of clinical and translational science2026

Insights from the development of an online toolkit to promote community-engaged substance use research in the Southwest Borderlands Region.

Andrew Gorvetzian, Maria Sanchez, Christina Phillips, Joseph Allbright, Alexandra Yonkovich, Cynthia Killough, Randy Benally, Janet Page-Reeves, Mary Alice Scott, Kimberly Page and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of clinical and translational science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Andrew GorvetzianAnthropology, The University of New Mexico Department of Anthropology, Albuquerque, NM, USA.
Maria SanchezInternal Medicine, The University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Christina PhillipsInternal Medicine, The University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Joseph AllbrightSocial Work, New Mexico State University, Las Cruces, NM, USA.
Alexandra YonkovichSocial Work, New Mexico State University, Las Cruces, NM, USA.
Cynthia KilloughClinical and Translational Science Center, University of New Mexico Health Sciences Center, Albuquerque, NM, USA.ORCID https://orcid.org/0000-0001-5893-0540
Randy BenallySouthwest Center for Advancing Clinical and Translational Innovation, University of New Mexico, Albuquerque, NM, USA.
Janet Page-ReevesFamily and Community Medicine, The University of New Mexico Health Sciences Center, Albuquerque, NM, USA.
Mary Alice ScottCenter for Health Services Research, University of North Carolina Wilmington, Wilmington, NC, USA.
Kimberly PageInternal Medicine, The University of New Mexico Health Sciences Center, Albuquerque, NM, USA.ORCID https://orcid.org/0000-0002-7120-1673
Ivan de la RosaSchool of Social Work, New Mexico State University, Las Cruces, NM, USA.ORCID https://orcid.org/0000-0002-2471-8127

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Underrepresented communities in the Southwestern United States Borderlands region face disproportionate substance use disorder (SUD) burdens yet remain largely excluded from clinical trials. No existing resource integrates health beliefs, research literacy, and vulnerability frameworks to support diverse community engagement in SUD clinical trials. Methods: We developed the Exploring Health Beliefs for Community Engagement and Diversity in Clinical Trials (EXPLORE) Toolkit through a multi-phase process (2021-2024) including systematic review of existing toolkits, domain development, platform design, individual interviews ( Results: Domain-specific toolkit importance ratings averaged 4.48-4.61 on a 5-point scale; 79% of participants rated the toolkit "very important" for promoting culturally competent research, and 64% were "very likely" to recommend it. Post-theater testing scores improved for perceived feasibility of conducting clinical research in participants' communities (pre: 7.19 vs. post: 7.94, 10-point scale) and research terminology understanding (pre: 7.97 vs. post: 8.74). Qualitative themes included cultural appropriateness, the role of community gatekeepers, and confidentiality concerns in rural and border communities. Conclusions: The EXPLORE Toolkit demonstrates promise for bridging researcher-community gaps in SUD clinical trials. Findings highlight the value of interdisciplinary, community-centered development and the need for ongoing cultural adaptation. The toolkit is freely available at https://www.exploretoolkit.org/.

Indexed as

Borderlands regioncommunity engagementinterdisciplinary scholarshipparticipant diversity in clinical trialssubstance use research

Identifiers

PMID42565092
PMCPMC13445463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.